These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
135 related items for PubMed ID: 8525534
1. Prolongation of survival of guinea pig heart grafts in cobra venom factor-treated rats by splenectomy. No additional effect of cyclosporine. Scheringa M, Schraa EO, Bouwman E, van Dijk H, Melief MJ, Ijzermans JN, Marquet RL. Transplantation; 1995 Dec 15; 60(11):1350-3. PubMed ID: 8525534 [No Abstract] [Full Text] [Related]
7. Prolonged survival of guinea pig hearts in rats after combined antibody and complement depletion. Scheringa M, Blanker R, Bemelman M, Schraa E, de Bruin R, Bouwman E, IJzermans J, Marquet R. Transplant Proc; 1995 Feb 15; 27(1):303-4. PubMed ID: 7879011 [No Abstract] [Full Text] [Related]
8. Vascular transplantation of Syrian hamster heart into Lewis rat: effect of brequinar, cyclosporine, cobra venom factor, and splenectomy. Schuurman HJ, Joergensen J, Kuipers H, Meerloo T, Lardelli P, Hiestand P, White DH, Schreier MH. Transplant Proc; 1994 Jun 15; 26(3):1217-9. PubMed ID: 8029893 [No Abstract] [Full Text] [Related]
9. Evidence that combination therapy using cobra venom factor, splenectomy, and deoxyspergualin is effective in guinea pig to rat cardiac xenotransplantation. Hayashi S, Ito M, Yokoyama I, Takagi H. Transplantation; 1994 Mar 15; 57(5):777-9. PubMed ID: 8140648 [No Abstract] [Full Text] [Related]
10. Rejection of guinea pig cardiac xenografts post-cobra venom factor therapy is associated with infiltration by mononuclear cells secreting interferon-gamma and diffuse endothelial activation. Hancock WW, Blakely ML, Van der Werf W, Bach FH. Transplant Proc; 1993 Oct 15; 25(5):2932. PubMed ID: 8212288 [No Abstract] [Full Text] [Related]
11. Role of antibody synthesis and complement activation in concordant xenograft retransplantation. Gannedahl G, Karlsson-Parra A, Wallgren A, Roos-Engstrand E, Nilsson B, Tötterman TH, Tufveson G. Transplantation; 1994 Aug 15; 58(3):337-44. PubMed ID: 8053058 [Abstract] [Full Text] [Related]
12. Immunobiology of delayed xenograft rejection. Marquet RL, van Overdam K, Boudesteijn EA, Bonthuis F, Kouwenhoven EA, de Bruin RW, Schraa EO, IJzermans JN. Transplant Proc; 1997 Aug 15; 29(1-2):955-6. PubMed ID: 9123605 [No Abstract] [Full Text] [Related]
13. Soluble complement receptor type 1 and cobra venom factor in discordant xenotransplantation. Candinas D, Lesnikoski BA, Robson SC, Scesney SM, Otsu I, Myiatake T, Marsh HC, Ryan US, Hancock WW, Bach FH. Transplant Proc; 1996 Apr 15; 28(2):581. PubMed ID: 8623282 [No Abstract] [Full Text] [Related]
14. Effects of cyclosporine, aspirin, and cobra venom factor on discordant cardiac xenograft survival in rats. Adachi H, Rosengard BR, Hutchins GM, Hall TS, Baumgartner WA, Borkon AM, Reitz BA. Transplant Proc; 1987 Feb 15; 19(1 Pt 2):1145-8. PubMed ID: 3547853 [No Abstract] [Full Text] [Related]
15. Delayed xenograft rejection in C3-depleted discordant (pig-to-baboon) cardiac xenografts treated with cobra venom factor. Kobayashi T, Taniguchi S, Ye Y, Niekrasz M, Kosanke S, Neethling FA, Wright LJ, Rose AG, White DJ, Cooper DK. Transplant Proc; 1996 Apr 15; 28(2):560. PubMed ID: 8623270 [No Abstract] [Full Text] [Related]
16. The effect of MX-1 on survival of discordant cardiac xenografts from guinea pig to rat. Kaji H, Platt JL, Sutherland DE, Inoue K, Mori C, Shiota K, Imamura M. Transpl Immunol; 1997 Mar 15; 5(1):70-2. PubMed ID: 9106338 [No Abstract] [Full Text] [Related]
17. The immunopathology of cardiac xenograft rejection in the guinea pig-to-rat model. Leventhal JR, Matas AJ, Sun LH, Reif S, Bolman RM, Dalmasso AP, Platt JL. Transplantation; 1993 Jul 15; 56(1):1-8. PubMed ID: 8333031 [Abstract] [Full Text] [Related]
19. Negligible role for NK cells and macrophages in delayed xenograft rejection. van Overdam KA, Verbakel CA, Kouwenhoven EA, van Rooijen N, de Bruin RW, IJzermans JN, Marquet RL. Transpl Int; 2000 Jul 15; 13 Suppl 1():S504-7. PubMed ID: 11112062 [Abstract] [Full Text] [Related]
20. Limitations to the feasibility of discordant liver transplantation. Schraa EO, Scheringa M, Buchner B, Marquet RL, LJzermans JN. Transplant Proc; 1996 Apr 15; 28(2):717-8. PubMed ID: 8623362 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]